Opendata, web and dolomites

U-TURBT SIGNED

A revolutionary shape memory alloy-based disposable device for bladder cancer removal

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "U-TURBT" data sheet

The following table provides information about the project.

Coordinator
CAMBRIDGE MECHATRONICS LIMITED 

Organization address
address: UNIT 17, BLOCK 6 THE WESTBROOK CENT
city: CAMBRIDGE
postcode: CB4 1YG
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://www.cambridgemechatronics.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CAMBRIDGE MECHATRONICS LIMITED UK (CAMBRIDGE) coordinator 50˙000.00

Map

 Project objective

Bladder cancer represents the 9th most common malignancy worldwide and the 4th most common in men. Globally approximately 2.5M people suffer from it, with 420,000 newly diagnosed cases each year. In Europe, a total of 118,000 new cases and 52,000 deaths are estimated annually. With population growth and ageing, the absolute incidence of bladder cancer might be further escalating. Despite the increasing incidences, the current treatments remain ineffective. The gold standard Trans-Urethral Resection of Bladder Tumour (TURBT) has up to 61% risk of tumour recurrence due to incomplete removal or tumour cell implantation during the procedure. CML introduces U-TURBT, an innovative disposable device for the treatment of bladder cancer. By covering and sealing the portion of bladder affected by the tumour, it avoids tumour cell spillage and dissemination. By minimising the risk of recurrence, U-TURBT improves patients’ health and quality of life, and cuts down the expenses of the healthcare providers relative to additional treatments. During the feasibility assessment, a go-to-market strategy and a supply chain will be established, as well as further development plan will be drafted. During the second phase of innovation project, CML will upgrade the device to permit en bloc bladder tumour resection and extrication. Large scale clinical trial will then be initiated for obtaining CE mark as a medical device

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "U-TURBT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "U-TURBT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

BEMYEYES (2019)

Specialized Help from Be My Eyes – harnessing technology to connect companies directly with their blind and visually impaired users

Read More  

AMBRPAY (2019)

Decentralized subscription payments with cryptocurrency

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More